Patient Care

By sabotaging one of the tuberculosis bacterium’s defenses against antibiotics, Weill Cornell Medicine investigators may have found a way to accelerate treatment for the disease and possibly overcome growing resistance to existing therapies.  

A new method for testing urinary tract infections yields more information than what conventional methods can offer, according to new research from investigators at Weill Cornell Medicine, Cornell’s Meinig School of Biomedical Engineering and NewYork-Presbyterian.

Dr. Francis Lee, a leading physician-scientist whose research focuses on anxiety disorders, has been named chairman of the Department of Psychiatry at Weill Cornell Medicine and psychiatrist-in-chief at NewYork-Presbyterian/Weill Cornell Medical Center, effective July 1.

An existing malaria drug could improve the effectiveness of a new class of cancer therapies, called glutaminase inhibitors, if used in combination, researchers at Weill Cornell Medicine-Qatar (WCM-Q) discovered in a new study.

For Ralph Hills, getting ready for minor back surgery in December 2014 was no big deal. At 71, the computer consultant was physically fit—regularly playing golf and tennis—and his heart and lungs were in good shape. So when he went for a routine pre-operative blood test, he never expected to get a call referring him to an oncologist near where he lives in suburban Connecticut.

Dr. Jane Salmon, associate dean for faculty affairs and a professor of medicine at Weill Cornell Medicine, has been elected an honorary member of the European League Against Rheumatism (EULAR). She is the second honoree from Weill Cornell and only the third American to receive this honor.

The Glickman Fellowship aims to attract future doctors to gynecological pncology by giving them an intensive, up-close look at the specialty.

Neurology tends to be a tough specialty. I remember our first day of residency at NewYork-Presbyterian/Weill Cornell Medical Center, Dr. [Jerome] Posner and Dr. [Fred] Plum [MD ’47] said, ‘For neurological patients, you are their last line of defense. Most people don’t understand neurological disease. They are afraid of it. It’s hard to deal with, and this is your job.’

Many cases of early-stage kidney cancer can be treated with a relatively new, nonsurgical procedure used to destroy tumors, a new study by a team led by Weill Cornell Medicine and NewYork-Presbyterian suggests.

Dr. Justin Kingery grew up in West Virginia coal country, a world away from Tanzania—but he felt at home in the East African nation from the beginning.

Dr. Anaïs Rameau is passionate about finding a way to restore these patients’ voices and, during Weill Cornell Medicine’s second annual Health Innovation Hackathon last month, challenged participants to do just that.

Patients who receive red blood cell (RBC) transfusions before, during or immediately after surgery are twice as likely to develop life-threatening, postoperative blood clots as those who don’t undergo RBC transfusions, according to a new study by Weill Cornell Medicine and NewYork-Presbyterian researchers.

Dr. Anjali Rajadhyaksha knows the effects of drug addiction, having lost a neighbor to the disease. Now a neuroscientist, she and her team hope to develop therapies to help those most vulnerable to dependence.

Recognizing the increasing importance of emergency medicine as an academic discipline, Weill Cornell Medicine has expanded the Division of Emergency Medicine into a comprehensive department effective July 1. 

Dr. Thomas Lee, MD ’79, chief medical officer of Press Ganey Associates Inc., has been awarded the Weill Cornell Medicine Alumni Association Award of Distinction.

A molecule promoting blood vessel growth in bone can create an environment suitable for bone-building formation, representing a potential target for new drugs to treat osteoporosis and fractures, according to new research by Weill Cornell Medicine scientists.

While studying abroad in India, Dr. Jyoti Mathad met a pregnant woman whose lack of access to maternal healthcare had devastating consequences.

Dr. Tony Rosen, an assistant professor of medicine at Weill Cornell Medicine and an attending emergency physician at NewYork-Presbyterian/Weill Cornell Medical Center, has been named the recipient of this year’s Jeffrey H. Silverstein Memorial Award for Emerging Investigators in the Surgical and Related Medical Specialties.

Weill Cornell Medicine has established a new Mentoring Academy that is dedicated to nurturing the next generation of healthcare leaders. 

NewYork-Presbyterian, in collaboration with Weill Cornell Medicine, Columbia University Irving Medical Center and the Fire Department of New York (FDNY), is expanding its fleet of Mobile Stroke Treatment Units (MSTU) to Queens and Brooklyn.